Results 291 to 300 of about 1,940,457 (361)

Mechanism and regulation of mitophagy in liver diseases: a review. [PDF]

open access: yesFront Cell Dev Biol
Liu S   +9 more
europepmc   +1 more source

Liver Disease Prediction Using Deep Learning

open access: diamond
V. Jyoshita   +5 more
openalex   +1 more source

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin   +11 more
wiley   +1 more source

Therapeutic Potential of Ellagic Acid in Liver Diseases. [PDF]

open access: yesMolecules
Wojtunik-Kulesza K   +5 more
europepmc   +1 more source

Additional file 2 of Human umbilical cord-derived mesenchymal stem cells ameliorate non-alcoholic fatty liver disease via activating TFEB-mediated autophagy in male mice

open access: gold
Huina Zhang   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy